681 related articles for article (PubMed ID: 6102234)
1. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand.
Pardthaisong T; Gray RH; McDaniel EB
Lancet; 1980 Mar; 1(8167):509-12. PubMed ID: 6102234
[TBL] [Abstract][Full Text] [Related]
2. Return of fertility after use of the injectable contraceptive Depo Provera: up-dated data analysis.
Pardthaisong T
J Biosoc Sci; 1984 Jan; 16(1):23-34. PubMed ID: 6230362
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy after removal of Norplant implants contraceptive.
Affandi B; Santoso SS; Djajadilaga ; Hadisaputra W; Moeloek FA; Prihartono J; Lubis F; Samil RS
Contraception; 1987 Aug; 36(2):203-9. PubMed ID: 3123134
[TBL] [Abstract][Full Text] [Related]
4. Return of fertility in women discontinuing injectable contraceptives.
Fotherby K; Howard G
J Obstet Gynaecol (Lahore); 1986 Apr; 6 Suppl 2():S110-5. PubMed ID: 12315276
[TBL] [Abstract][Full Text] [Related]
5. Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department.
Potter LS; Dalberth BT; Cañamar R; Betz M
Contraception; 1997 Nov; 56(5):305-12. PubMed ID: 9437559
[TBL] [Abstract][Full Text] [Related]
6. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
Polaneczky M; Liblanc M
J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
[TBL] [Abstract][Full Text] [Related]
7. Reasons for contraceptive discontinuation in women 20-39 years old in New Zealand.
Colli E; Tong D; Penhallegon R; Parazzini F
Contraception; 1999 Apr; 59(4):227-31. PubMed ID: 10457866
[TBL] [Abstract][Full Text] [Related]
8. The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation.
Pardthaisong T; Yenchit C; Gray R
Contraception; 1992 Apr; 45(4):313-24. PubMed ID: 1387602
[TBL] [Abstract][Full Text] [Related]
9. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.
Lei ZW; Wu SC; Garceau RJ; Jiang S; Yang QZ; Wang WL; Vander Meulen TC
Contraception; 1996 Jun; 53(6):357-61. PubMed ID: 8773423
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
[TBL] [Abstract][Full Text] [Related]
11. Depo-Provera use in an Australian metropolitan practice.
Fraser IS; Dennerstein GJ
Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
[TBL] [Abstract][Full Text] [Related]
12. Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR Task Force on Hormonal Contraception.
Buckshee K; Chatterjee P; Dhall GI; Hazra MN; Kodkany BS; Lalitha K; Logambal A; Manchanda P; Nanda UK; RaiChoudhury G
Contraception; 1995 Apr; 51(4):237-42. PubMed ID: 7796589
[TBL] [Abstract][Full Text] [Related]
13. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
Swenson I; Khan AR; Jahan FA
Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
[TBL] [Abstract][Full Text] [Related]
14. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation.
Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A
Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739
[TBL] [Abstract][Full Text] [Related]
16. In utero exposure to steroid contraceptives and outcome of pregnancy.
Pardthaisong T; Gray RH
Am J Epidemiol; 1991 Oct; 134(8):795-803. PubMed ID: 1835282
[TBL] [Abstract][Full Text] [Related]
17. [Contraception with injectable long-acting preparation depo-provera].
Prilepskaia VN; Kondrikov NI; Tagieva TT
Akush Ginekol (Mosk); 1995; (3):7-10. PubMed ID: 7653732
[TBL] [Abstract][Full Text] [Related]
18. Some effects of depo-medroxyprogesterone acetate (DMPA): observations in the nursing infant and in the long-term user.
Dahlberg K
Int J Gynaecol Obstet; 1982 Feb; 20(1):43-8. PubMed ID: 6126406
[TBL] [Abstract][Full Text] [Related]
19. Forearm bone density in users of Depo-Provera as a contraceptive method.
Bahamondes L; Perrotti M; Castro S; Faúndes D; Petta C; Bedone A
Fertil Steril; 1999 May; 71(5):849-52. PubMed ID: 10231044
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
Taneepanichskul S; Intaraprasert S; Theppisai U; Chaturachinda K
Contraception; 1997 Jul; 56(1):1-3. PubMed ID: 9306024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
